PKMYT1 is a crucial promoter in the development of hepatocellular carcinoma (Aguiar et al., 2017; Liu et al., 2017), and overexpression of PKMYT1 indicates a poor prognosis and enhances proliferation and tumorigenesis in non-small cell lung cancer (Sun et al., 2019). Here, PKMYT1 is linked to non-small cell lung carcinoma.